PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Belite Bio, Inc.
Start Date
January 12, 2024
End Date
December 31, 2028
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Belite Bio, Inc.
Start Date
January 12, 2024
End Date
December 31, 2028